Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201507155280N19
IRCT201507155280N19
Completed
Phase 2

Metamphetamine associated psychosis treatment with haloperidol versus rispridone: a clinical trial

Vice chancellor for research of University of Social Welfare and Rehabilitation Sciences0 sites44 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMethamphetamine-associated psychosis.Mental and behavioural disorders due to use of other stimulants, including caffeine

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Methamphetamine-associated psychosis.
Sponsor
Vice chancellor for research of University of Social Welfare and Rehabilitation Sciences
Enrollment
44
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research of University of Social Welfare and Rehabilitation Sciences

Eligibility Criteria

Inclusion Criteria

  • •Patient in the age range 18 to 60; signing informed consent. Exclusion criteria: presence of other psychiatric disorders; abusing of other psycho stimulant drugs; comorbid neurological disorders; mental retardation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Psychosocial Treatment for Methamphetamine Use Disorders in South Africa: A Pilot Study of a Cognitive Behavioural Therapy ProgramMethamphetamine Use Disorders
PACTR20131000058929560
Completed
Not Applicable
Mentalization-Based Treatment for Psychosis: a randomized controlled trial for outpatients with a nonaffective psychotic disorder.Non-affective psychotic disorders10039628
NL-OMON44966Academisch Medisch Centrum90
Recruiting
Not Applicable
Tu Whakaruruhau: The New Zealand Methamphetamine Treatment Evaluation StudySubstance DependenceMethamphetamine dependenceMental Health - Addiction
ACTRN12623000438651niversity of Auckland320
Active, not recruiting
Not Applicable
Examine whether treatment with methylphenidate facilitates work rehabilitation for persons with long-term pain and mental fatigue after traumatic brain injury.ong-term pain and mental fatigue after traumatic brain injury and work rehabilitation.Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2015-002096-14-SESahlgrenska University Hospital
Completed
Not Applicable
We Can Do This: Web-based therapeutic intervention for reducing methamphetamine use amongst Aboriginal and Torres Strait Islander people: Randomised wait-list control Trial
ACTRN12619000134123South Australian Health and Medical Research Institute210